| Title : Basal forebrain atrophy correlates with amyloid beta burden in Alzheimer's disease - Kerbler_2015_Neuroimage.Clin_7_105 |
| Author(s) : Kerbler GM , Fripp J , Rowe CC , Villemagne VL , Salvado O , Rose S , Coulson EJ |
| Ref : Neuroimage Clin , 7 :105 , 2015 |
| PubMedID: 25610772 |
| Title : Management Impact of FDG-PET in Dementia: Results from a Tertiary Center Memory Clinic - Elias_2014_J.Alzheimers.Dis_42_885 |
| Author(s) : Elias A , Woodward M , Rowe CC |
| Ref : J Alzheimers Dis , 42 :885 , 2014 |
| PubMedID: 24961944 |
| Title : Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing - Sona_2012_Int.Psychogeriatr_24_197 |
| Author(s) : Sona A , Zhang P , Ames D , Bush AI , Lautenschlager NT , Martins RN , Masters CL , Rowe CC , Szoeke C , Taddei K , Ellis KA |
| Ref : Int Psychogeriatr , 24 :197 , 2012 |
| PubMedID: 21749739 |
| Title : Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET - Ellis_2009_Psychopharmacology.(Berl)_202_79 |
| Author(s) : Ellis JR , Nathan PJ , Villemagne VL , Mulligan RS , Saunder T , Young K , Smith CL , Welch J , Woodward M , Wesnes KA , Savage G , Rowe CC |
| Ref : Psychopharmacology (Berl) , 202 :79 , 2009 |
| PubMedID: 18949462 |